Atlas Lithium Valuation
Is ATLX undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ATLX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ATLX ($7.51) is trading below our estimate of fair value ($49.88)
Significantly Below Fair Value: ATLX is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ATLX?
Key metric: As ATLX barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.
| What is ATLX's PB Ratio? | |
|---|---|
| PB Ratio | 4.9x |
| Book | US$23.28m |
| Market Cap | US$114.59m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 190.7x |
| Enterprise Value/EBITDA | -2.1x |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does ATLX's PB Ratio compare to its peers?
| Company | Forward PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 5.2x | ||
GDRZ.F Gold Reserve | 5.6x | n/a | US$212.5m |
ABAT American Battery Technology | 1.1x | n/a | US$62.3m |
ORGN Origin Materials | 0.4x | 27.7% | US$158.9m |
SGML Sigma Lithium | 13.7x | 215.9% | US$1.4b |
ATLX Atlas Lithium | 4.9x | 145.2% | US$114.6m |
Price-To-Book vs Peers: ATLX is good value based on its Price-To-Book Ratio (4.9x) compared to the peer average (5.2x).
Price to Book Ratio vs Industry
How does ATLX's PB Ratio compare vs other companies in the US Metals and Mining Industry?
Price-To-Book vs Industry: ATLX is expensive based on its Price-To-Book Ratio (4.9x) compared to the US Metals and Mining industry average (1.7x).
Price to Book Ratio vs Fair Ratio
What is ATLX's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | 4.9x |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate ATLX's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$7.51 | US$27.67 +268.4% | 44.3% | US$45.00 | US$19.00 | n/a | 3 |
| Nov ’25 | US$9.66 | US$29.83 +208.8% | 37.0% | US$45.00 | US$19.00 | n/a | 3 |
| Oct ’25 | US$6.60 | US$40.50 +513.6% | 29.7% | US$55.00 | US$25.50 | n/a | 3 |
| Sep ’25 | US$10.37 | US$40.50 +290.5% | 29.7% | US$55.00 | US$25.50 | n/a | 3 |
| Aug ’25 | US$10.73 | US$40.50 +277.4% | 29.7% | US$55.00 | US$25.50 | n/a | 3 |
| Jul ’25 | US$11.63 | US$43.67 +275.5% | 18.7% | US$55.00 | US$36.00 | n/a | 3 |
| Jun ’25 | US$14.24 | US$43.67 +206.6% | 18.7% | US$55.00 | US$36.00 | n/a | 3 |
| May ’25 | US$15.00 | US$43.67 +191.1% | 18.7% | US$55.00 | US$36.00 | n/a | 3 |
| Apr ’25 | US$19.30 | US$50.33 +160.8% | 34.8% | US$75.00 | US$36.00 | n/a | 3 |
| Mar ’25 | US$17.19 | US$55.33 +221.9% | 26.9% | US$75.00 | US$39.00 | n/a | 3 |
| Feb ’25 | US$22.24 | US$55.33 +148.8% | 26.9% | US$75.00 | US$39.00 | n/a | 3 |
| Jan ’25 | US$31.28 | US$58.00 +85.4% | 21.0% | US$75.00 | US$47.00 | n/a | 3 |
| Dec ’24 | US$24.87 | US$56.33 +126.5% | 17.5% | US$70.00 | US$47.00 | n/a | 3 |
| Nov ’24 | US$22.32 | US$56.33 +152.4% | 17.5% | US$70.00 | US$47.00 | US$9.66 | 3 |
| Oct ’24 | US$30.64 | US$56.33 +83.9% | 17.5% | US$70.00 | US$47.00 | US$6.60 | 3 |
| Sep ’24 | US$25.79 | US$57.67 +123.6% | 16.4% | US$70.00 | US$47.00 | US$10.37 | 3 |
| Aug ’24 | US$25.28 | US$55.25 +118.6% | 16.7% | US$70.00 | US$47.00 | US$10.73 | 4 |
| Jul ’24 | US$21.42 | US$55.00 +156.8% | 19.3% | US$70.00 | US$47.00 | US$11.63 | 3 |
| Jun ’24 | US$21.85 | US$55.00 +151.7% | 19.3% | US$70.00 | US$47.00 | US$14.24 | 3 |
| May ’24 | US$38.89 | US$36.00 -7.4% | 37.1% | US$50.00 | US$18.00 | US$15.00 | 3 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.
Discover undervalued companies
Trinseo
US$122.5m
Operates as a specialty material solutions provider in the United States, Europe, the Asia-Pacific, and internationally.
TSE
US$3.46
7D
-9.7%
1Y
-49.0%
Huntsman
US$3.4b
Manufactures and sells diversified organic chemical products worldwide.
HUN
US$19.55
7D
-3.6%
1Y
-21.6%
CMOC Group
HK$163.7b
Engages in the mining, beneficiation, smelting, and refining of base and rare metals.
CMCL.F
HK$0.79
7D
-12.6%
1Y
43.8%